Cargando…

Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care

AIMS: Data on the clinical course of hypertrophic cardiomyopathy (HCM) are mainly derived from tertiary HCM centre studies, and knowledge of clinical outcomes of patients leaving specialty care and returning to local physicians is limited due to gaps between clinical encounters or complete loss of f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garmany, Ramin, Bos, J. Martijn, Ommen, Steve R., Ackerman, Michael J., Geske, Jeffrey B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192262/ https://www.ncbi.nlm.nih.gov/pubmed/36987533 http://dx.doi.org/10.1002/ehf2.14345

Ejemplares similares

Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy
por: Garmany, Ramin, et al.
Publicado: (2023)

Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy
por: Siontis, Konstantinos C., et al.
Publicado: (2019)

Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports
por: Dewaswala, Nakeya, et al.
Publicado: (2022)

Conversion of left atrial volume to diameter for automated estimation of sudden cardiac death risk in hypertrophic cardiomyopathy
por: Bhopalwala, Huzefa, et al.
Publicado: (2020)

In-Hospital Outcomes of Acute Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2022)

Tandem deep learning and logistic regression models to optimize hypertrophic cardiomyopathy detection in routine clinical practice
por: Maanja, Maren, et al.
Publicado: (2022)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
por: Siontis, Konstantinos C., et al.
Publicado: (2014)

Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2021)

Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
por: Patlolla, Sri Harsha, et al.
Publicado: (2022)

Association of Preoperative Sleep-Disordered Breathing With Functional Status After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2022)

Natural language processing of implantable cardioverter-defibrillator reports in hypertrophic cardiomyopathy: A paradigm for longitudinal device follow-up
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy
por: Bois, John P., et al.
Publicado: (2023)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
por: Du, Darson, et al.
Publicado: (2022)

Exuberant late gadolinium enhancement in hypertrophic cardiomyopathy as a precursor to ‘burn out’
por: Gweun, John, et al.
Publicado: (2022)

Predictors of Exercise Capacity in Patients with Hypertrophic Obstructive Cardiomyopathy
por: Smith, Joshua R., et al.
Publicado: (2018)

Squat-to-stand provocation of dynamic left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: a case report
por: Peng, Lillian T, et al.
Publicado: (2020)

MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy
por: McNamara, James W., et al.
Publicado: (2017)

Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report
por: Pham, Justin H., et al.
Publicado: (2023)

Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2–Mediated COVID-19
por: Bos, J. Martijn, et al.
Publicado: (2020)

International Practice Patterns in the Detection and Management of Arrhythmias in Patients With Hypertrophic Cardiomyopathy
por: Cheung, Matthew, et al.
Publicado: (2022)

Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: Alabdaljabar, Mohamad S., et al.
Publicado: (2023)

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2019)

Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy
por: Lee, Hyun-Jung, et al.
Publicado: (2022)

Predicting the clinical course in hypertrophic cardiomyopathy using thallium‐201 myocardial scintigraphy
por: Hamada, Mareomi, et al.
Publicado: (2021)

Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator
por: Francia, Pietro, et al.
Publicado: (2023)

Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Asymptomatic Apical Hypertrophic Cardiomyopathy in an Elite Competitive Athlete
por: Huang, Athena L., et al.
Publicado: (2022)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy: Results of the Prospective, Observational, Multinational, “Lifestyle and Exercise in HCM” (LIVE-HCM) Study
por: Lampert, Rachel, et al.
Publicado: (2023)

A Case of Chagas Cardiomyopathy in Western Virginia: Worlds Away?
por: Vattikonda, Kiriti, et al.
Publicado: (2023)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

What Causes Hypertrophic Cardiomyopathy?
por: Maron, Bradley A., et al.
Publicado: (2022)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

Major Clinical Issues in Hypertrophic Cardiomyopathy
por: Lee, Hyun-Jung, et al.
Publicado: (2022)

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: El Masry, Hicham, et al.
Publicado: (2008)

Clinical course and outcomes in adults with co-occurring hypertrophic cardiomyopathy and hypertension: a scoping review protocol
por: Arabadjian, Milla, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e1tiq0p0rlcbjrks786dfal1fs